Healing together: Results from a pilot trial of 3,4-Methylenedioxymethamphetamine-enhanced cognitive-behavioral conjoint therapy for posttraumatic stress disorder.
J Trauma Stress September 4, 2026 DOI: 10.1002/jts.70126 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pilot trial Pilot study Peer reviewed |
|---|---|
| Population | Couples in which one partner has posttraumatic stress disorder |
| Interventions | 3 4-Methylenedioxymethamphetamine Cognitive-behavioral conjoint therapy |
| Topics | MDMA |
| Key findings | MDMA-enhanced cognitive-behavioral conjoint therapy was feasible and acceptable, and was associated with clinically meaningful reductions in PTSD symptoms and improvements in relationship satisfaction, suggesting promise for this treatment approach. |
Abstract
Healing together: Results from a pilot trial of 3,4-Methylenedioxymethamphetamine-enhanced cognitive-behavioral conjoint therapy for posttraumatic stress disorder.